Where does Hongene Biotech Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hongene Biotech Corporation ranks #18,728 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hongene Biotech Corporation hold?

Hongene Biotech Corporation holds 15 US utility patents granted between 2023 and 2024, spanning 13 technology areas.

What is Hongene Biotech Corporation's Innovation Score?

Hongene Biotech Corporation has an Innovation Score of 57.3 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hongene Biotech Corporation focus on?

Hongene Biotech Corporation's top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 14 patents, ranking #59 of 896 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Hongene Biotech Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Hongene Biotech Corporation.

What does claim depth mean for Hongene Biotech Corporation's patents?

Hongene Biotech Corporation's patents average 28.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hongene Biotech Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Hongene Biotech Corporation

USPTO PatentsView assignee record - 15 granted patents across 13 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hongene ranks #18,728 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 13 technology areas.

#18,728
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.3/100): 28.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18728 · US Corporation #18,728 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #18,728/49,997
PHOTO-FINISH Holaira
CPC-FOCUS C07H · 13 areas
INNOV-PAR 57.3/100
CLAIMS-DENSE 28.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2024 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Holaira, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hongene’s 57.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (17%) Velocity 20.0 pts (35%) Breadth 12.7 pts (22%) Claim depth 15.0 pts (26%)

Qualcomm Incorporated · highest

85
Benteler Automobilte… · near

57
Hongene Biotech · this assignee

57
Navico Holding AS · near

57
THE University OF… · near

57
Wayne Fueling Systems · near

57
3D Lighting… · lowest

7

What this shows Hongene's Innovation Score is 57.3/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hongene?

Each dot is one of Hongene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hongene’s own 28.7 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hongene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hongene's grants concentrate

Hongene Biotech Corporation is a focused PatentsView assignee: 13 CPC subclasses with 93.3% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2024 (10 grants) versus a trough of 5 in 2023. By volume, Hongene sits between Holaira, Inc. and House of Design LLC.

Hongene's three-year grant acceleration

Hongene Biotech Corporation shows 15 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Holaira

15
Homax Products

15
Honda elesys

15
Hong Kong Ivps In…

15
Hoshizaki America

15
Hospital for Spec…

15
Houghton Mifflin…

15
House of Design

15
Hongene Biotech ◀

15

What this shows Hongene holds 15 patents at rank #18,732, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hongene

By rank, the assignees closest to #18,732 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Hongene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hongene, neither rank-band nor same-CPC leaders (those blocks stay above). In C07H (Sugars), Hongene ranks #59 of 896 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Wayne Fueling Systems LLC 57 Navico Holding AS 57 Benteler Automobiltechnik GMBH 57 THE University OF Akron 57

Hongene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Hongene Biotech Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	5	33.3%
2024	10	66.7%

Which technologies does Hongene Biotech Corporation patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 14

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 6

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C07C - Acyclic OR Carbocyclic Compounds 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C08L - Compositions OF Macromolecular Compounds 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07K - Peptides 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hongene Biotech Corporation's patent record in context - here's where to go next.

Hongene Biotech Corporation's lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 93.3% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #18,728 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hongene Biotech Corporation against Holaira, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.